Broome Oncology

Latest Cancer News

Abemaciclib Receives FDA Breakthrough Therapy Designation in Advanced Breast Cancer (10-9-2015)
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to abemaciclib, a cyclin-dependent kinase (CDK) 4 and 6 inhibitor, for patients with refractory hormone-receptor-positive... Continue Reading

Low Oncotype® Recurrence Score® Identifies Group of Women with Early Stage Breast Cancer That can Avoid Chemotherapy (10-8-2015)
The results of a study presented at the European Cancer Congress demonstrate that early-stage breast cancer patients with a low Oncotype DX® Recurrence Score® result of 10 or less who received hormonal... Continue Reading

Zelboraf® Appears Active in Hairy Cell Leukemia That Has Progressed After Other Treatment (10-7-2015)
The medication Zelboraf® (vemurafenib) appears active in the treatment of hairy cell leukemia (HCL) that had progressed after previous therapy. These findings were published in New England Journal of... Continue Reading

More Cancer News


169 Riverside Drive
Binghamton, NY 13905
(607) 798-5307
Click here to visit the Lourdes website
Johnson City
30 Harrison Street
Johnson City, NY 13790
(607) 763-6850
Click here to visit the UHS website
Office Hours (both locations)
Monday – Thursday 8:00am – 4:30pm
Friday 8:00am- 12:00pm